| 1 | Long-term survival of a patient with microsatellite-stable refractory colorectal cancer with regorafenib and PD-1 inhibitor sintilimab: a case report and review of literature. 2021;21: doi: 10.1186/s12876-021-01950-y |
| 2 | Treatment of KRAS Mutant Microsatellite Stabilized Advanced Colorectal Cancer. 2023;13:8128 doi: 10.12677/ACM.2023.1351137 |
| 3 | Pathological Features and Prognostication in Colorectal Cancer. 2021;28:5356 doi: 10.3390/curroncol28060447 |
| 4 | Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival. 2022;13:828 doi: 10.18632/oncotarget.28242 |
| 5 | Classification of GTP-dependent K-Ras4B active and inactive conformational states. 2023;158:091104 doi: 10.1063/5.0139181 |
| 6 | Therapeutic Potential of Naturally Occurring Small Molecules to Target the Wnt/β-Catenin Signaling Pathway in Colorectal Cancer. 2022;14:403 doi: 10.3390/cancers14020403 |
| 7 | Concurrent RAS and RAS/BRAF V600E Variants in Colorectal Cancer: More Frequent Than Expected? A Case Report. 2022;12: doi: 10.3389/fonc.2022.863639 |
| 8 | Prognostic Value of KRAS Mutations in Colorectal Cancer Patients. 2022;14:3320 doi: 10.3390/cancers14143320 |
Journal of Cancer Metastasis and Treatment
